Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Myriad Genetics Inc

NASDAQ: MYGN · Life Sciences · 8 alerts · CIK 899923

Share price
$5.57Close, Nov 16
Market cap
$534M
Shares outstanding
95.92MLatest SEC cover page
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic SubstancesSIC 2835

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Myriad Genetics Inc filings on SEC EDGAR ↗

9:07 AM ET 8-K
Cybersecurity Incident

Myriad Genetics Cybersecurity Incident

Myriad Genetics detected unauthorized access to its IT network on November 2, 2026, leading to a temporary suspension of testing operations and order management systems. The company has engaged external experts to investigate the scope of the breach, including potential access to patient records, though most systems have since returned to normal operations. Management currently believes the incident will not have a material adverse effect on the business.

8:37 AM ET 8-K
Divestiture

Myriad Genetics Divestiture to Laboratory Corporation of America for $210M

Myriad Genetics has entered into a definitive agreement to sell its prenatal health testing business, including the Foresight, Prequel, and SneakPeek tests, to Labcorp for $210 million in cash. The divestiture is part of a strategic review to focus on the company's cancer care continuum and is expected to close by early 2027.

Value
$210M
Counterparty
Laboratory Corporation of America

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.